Showing results (1511-1520 of 1,690) with videos related to

Sort By:
Pageof 169
JAMA|November 3, 2005
Randomized trials stopped early for benefit: a systematic reviewVictor M Montori, P J Devereaux, Neill K J Adhikari, et al.
Journal of Clinical Epidemiology|April 17, 2017
GRADE equity guidelines 1: considering health equity in GRADE guideline development: introduction and rationaleVivian A Welch, Elie A Akl, Gordon Guyatt, et al.
BMJ (Clinical Research Ed.)|June 6, 2020
Evaluating the credibility of anchor based estimates of minimal important differences for patient reported outcomes: instrument development and reliability studyTahira Devji, Alonso Carrasco-Labra, Anila Qasim, et al.
BMJ (Clinical Research Ed.)|February 19, 2025
Commonly used interventional procedures for non-cancer chronic spine pain: a clinical practice guidelineJason W Busse, Stéphane Genevay, Arnav Agarwal, et al.
European Heart Journal|June 26, 2019
Risk of stroke and other adverse outcomes in patients with perioperative atrial fibrillation 1 year after non-cardiac surgeryDavid Conen, Pablo Alonso-Coello, James Douketis, et al.
Journal of Clinical Epidemiology|June 7, 2017
A systematic survey on reporting and methods for handling missing participant data for continuous outcomes in randomized controlled trialsYuqing Zhang, Ivan D Flórez, Luis E Colunga Lozano, et al.
BMJ (Clinical Research Ed.)|July 8, 2026
Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysisKailei Nong, Qingyang Shi, Xinran Xie, et al.
Critical Care Medicine|December 5, 2014
Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients*Wendy Lim, Maureen Meade, Francois Lauzier, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|August 27, 2021
Ketamine administration for acute painful sickle cell crisis: A randomized controlled trialMohammed S Alshahrani, Amal H AlSulaibikh, Mohamed R ElTahan, et al.
BMJ (Clinical Research Ed.)|May 12, 2021
SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guidelineSheyu Li, Per Olav Vandvik, Lyubov Lytvyn, et al.
Pageof 169